Engineering Controls and Facility Design

About the Course
This course will provide the learner with the knowledge to about the design of cleanroom facilities and the engineering controls used

Target Audience
This course is designed for those working in a compounding controlled environment that need to understand how to properly operate within the primary and secondary engineering controls and have an understanding of the design of a cleanroom

Statement of Need
Technicians need to have an understanding of how to properly operate inside a cleanroom environment and how the cleanroom works while minimizing the risk of contamination.

Learning Objectives:
At the conclusion of this activity, Pharmacists should be able to:

1. List the 4 design principles of building a cleanroom
2. Arrange the order of cleaning for both the Primary and Secondary Engineering Controls
3. List the two broad categories of disinfectants
4. Define contact time, detergent, cleaning, disinfection, sanitization, sterilization and asepsis
5. Describe the techniques used for cleaning controlled environment surfaces

At the conclusion of this activity, Technicians should be able to:

1. Explain the difference between cleaning and disinfection
2. Arrange the order of cleaning for both the Primary and Secondary Engineering Controls
3. List the two broad categories of disinfectants
4. Define contact time, detergent, cleaning, disinfection, sanitization, sterilization and asepsis
5. Describe the techniques used for cleaning controlled environment surfaces

Faculty
Seth DePasquale, R.Ph.

Faculty Disclosure

All planners, speakers, authors, and reviewers involved with content development for continuing education activities provided by Lyceum are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity. 

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses. 

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.